Cargando…

P1664: IMPACT OF A PROTOCOL USING RITUXIMAB FOR PREVENTION OF RELAPSE IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP)

Detalles Bibliográficos
Autores principales: Marín Sánchez, E., Fernandes, E., López Marín, J., Tarín, F., Hernandez Mateo, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430794/
http://dx.doi.org/10.1097/01.HS9.0000849512.36608.fe
_version_ 1784779874657894400
author Marín Sánchez, E.
Fernandes, E.
López Marín, J.
Tarín, F.
Hernandez Mateo, L.
author_facet Marín Sánchez, E.
Fernandes, E.
López Marín, J.
Tarín, F.
Hernandez Mateo, L.
author_sort Marín Sánchez, E.
collection PubMed
description
format Online
Article
Text
id pubmed-9430794
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94307942022-08-31 P1664: IMPACT OF A PROTOCOL USING RITUXIMAB FOR PREVENTION OF RELAPSE IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP) Marín Sánchez, E. Fernandes, E. López Marín, J. Tarín, F. Hernandez Mateo, L. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430794/ http://dx.doi.org/10.1097/01.HS9.0000849512.36608.fe Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Marín Sánchez, E.
Fernandes, E.
López Marín, J.
Tarín, F.
Hernandez Mateo, L.
P1664: IMPACT OF A PROTOCOL USING RITUXIMAB FOR PREVENTION OF RELAPSE IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP)
title P1664: IMPACT OF A PROTOCOL USING RITUXIMAB FOR PREVENTION OF RELAPSE IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP)
title_full P1664: IMPACT OF A PROTOCOL USING RITUXIMAB FOR PREVENTION OF RELAPSE IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP)
title_fullStr P1664: IMPACT OF A PROTOCOL USING RITUXIMAB FOR PREVENTION OF RELAPSE IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP)
title_full_unstemmed P1664: IMPACT OF A PROTOCOL USING RITUXIMAB FOR PREVENTION OF RELAPSE IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP)
title_short P1664: IMPACT OF A PROTOCOL USING RITUXIMAB FOR PREVENTION OF RELAPSE IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP)
title_sort p1664: impact of a protocol using rituximab for prevention of relapse in patients with acquired thrombotic thrombocytopenic purpura (attp)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430794/
http://dx.doi.org/10.1097/01.HS9.0000849512.36608.fe
work_keys_str_mv AT marinsancheze p1664impactofaprotocolusingrituximabforpreventionofrelapseinpatientswithacquiredthromboticthrombocytopenicpurpuraattp
AT fernandese p1664impactofaprotocolusingrituximabforpreventionofrelapseinpatientswithacquiredthromboticthrombocytopenicpurpuraattp
AT lopezmarinj p1664impactofaprotocolusingrituximabforpreventionofrelapseinpatientswithacquiredthromboticthrombocytopenicpurpuraattp
AT tarinf p1664impactofaprotocolusingrituximabforpreventionofrelapseinpatientswithacquiredthromboticthrombocytopenicpurpuraattp
AT hernandezmateol p1664impactofaprotocolusingrituximabforpreventionofrelapseinpatientswithacquiredthromboticthrombocytopenicpurpuraattp